Ira Leviton
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Antifungal resistance and susceptibility 1
- Co-authors
- Edward S. Eisenberg (1 shared paper)R Soeiro (1 shared paper)Michael H. Miller (3 shared papers)Henry Fraimow (2 shared papers)Thomas J. Dougherty (2 shared papers)Maria Amodio-Groton (1 shared paper)John Greenman (1 shared paper)Ross G. Hewitt (1 shared paper)
- Journals
- Cancer Investigation (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Clinical Infectious Diseases (1 paper)Critical Care Medicine (1 paper)Journal of Bacteriology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Ira Leviton
11 papers receiving 314 citations
Peers
Comparison fields: 5 of 77
- Infectious Diseases 158
- Molecular Medicine 40
- Nephrology 37
- Endocrinology 21
- Emergency Medical Services 25
Countries citing papers authored by Ira Leviton
This map shows the geographic impact of Ira Leviton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ira Leviton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ira Leviton more than expected).
Fields of papers citing papers by Ira Leviton
This network shows the impact of papers produced by Ira Leviton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ira Leviton. The network helps show where Ira Leviton may publish in the future.
Co-authors
The 25 scholars most cited alongside Ira Leviton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 116 | |
| 2 | 1998 | 74 | |
| 3 | 1998 | 33 | |
| 4 | 1997 | 32 | |
| 5 | 1991 | 29 | |
| 6 | 1995 | 21 | |
| 7 | 2022 | 15 | |
| 8 | 2003 | 5 | |
| 9 | 1999 | 5 | |
| 10 | 2014 | 1 | |
| 11 | 1998 | 1 | |
| 12 | 1999 | 1 |
About Ira Leviton
Ira Leviton is a scholar working on Pharmacology, Infectious Diseases, Molecular Medicine, Molecular Biology and Epidemiology, having authored 12 papers that have together received 333 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Antibiotic Resistance in Bacteria (3 papers), Bacterial Genetics and Biotechnology (2 papers), Antibiotic Use and Resistance (1 paper), Patient Satisfaction in Healthcare (1 paper), Antifungal resistance and susceptibility (1 paper), Bacterial Infections and Vaccines (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Infectious Diseases (158 citations), Molecular Medicine (40 citations), Nephrology (37 citations), Endocrinology (21 citations) and Emergency Medical Services (25 citations). Ira Leviton has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Edward S. Eisenberg, R Soeiro, Michael H. Miller, Henry Fraimow, Thomas J. Dougherty, Maria Amodio-Groton, John Greenman, Ross G. Hewitt, William M. Valenti and John Carey. Their work appears in journals such as Cancer Investigation, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Critical Care Medicine and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.